Hutch News
Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal
T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers
Good News: Mustang Bio licenses Fred Hutch CD20 CAR-T immunotherapy for lymphoma trial
Celebrating faculty and staff achievements
Unique set of tissue samples ‘ready to teach’ lessons about pediatric leukemia
Hutch-based repository leads to lifesaving treatments for young cancer patient
Bringing a leukemia treatment back to life with precision medicine
New research writes latest chapter in one drug's story
Remembering leukemia researcher Dr. Steve Collins
Among 'a lot of brilliant guys,' the leukemia clinician-researcher stood out for his science — and much more
Good News: Dr. Glenda Gray among Time magazine’s ‘100 most influential’
Celebrating faculty and staff achievements
A Q&A with immunotherapy researcher Dr. Rachel Perret
As part of a world-class immunotherapy research team, Perret is working her ‘dream job’ — trying to bring T-cell therapy to all who need it
Immunotherapy shows promise in preventing leukemia relapse
Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission
Umbilical cord blood transplant linked to lower relapse in high-risk leukemia patients
Study compares ‘alternative’ donor source vs. traditional transplantation of blood stem cells from an adult, unrelated donor
Good News at Fred Hutch
Dr. Roland Walter receives two grant awards for acute leukemia research; Dr. Jonathan Bricker to keynote behavioral therapy conference; Dr. Benjamin Anderson chairs NCCN committee that publishes clinical-practice guidelines for cervical cancer
'Have we come a long way'
A bench, a book and a mother’s memories of her son’s 1983 bone marrow transplant
Cord blood: 'The biggest blessing ever'
Cord blood: a lifesaving option for those in need of a transplant but cannot find a matched donor
The FedEx factor: How handling and storage of patient blood samples can impact cancer research
New study reveals how a seemingly major leukemia discovery turned scientific cautionary tale about how standard blood collection can alter results
They make you feel like family
SCCA House is a home away from home for patients like Donald and Beverly Shaw during treatment
Hematologist winse $375,000 for AML research
Alex's Lemonade Stand Foundation supports Dr. Roland Walter's study of cancer cells that fuel acute myeloid leukemia and work to improve therapeutic response and prognosis
Antibody-Targeted Chemotherapy-Induced Remission and Stem Cell Transplantation Prolong Disease-Free Survival for Leukemia Patients
Fred Hutchinson Cancer Research Center Researcher Presents Study Results at the American Society of Hematology Meeting in San Francisco